Hall Laurie J Trustee Ionis Pharmaceuticals Inc Transaction History

Hall Laurie J Trustee

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$37.12 - $46.52 $2,598 - $3,256	-70 Reduced 37.84%	115 $4,000
Q3 2022 Oct 11, 2022	SELL	$36.54 - $48.66 $3,105 - $4,136	-85 Reduced 31.48%	185 $8,000
Q3 2021 Oct 04, 2021	SELL	$33.54 - $40.55 $5,366 - $6,488	-160 Reduced 37.21%	270 $9,000
Q2 2021 Jul 07, 2021	SELL	$34.54 - $47.25 $18,997 - $25,987	-550 Reduced 56.12%	430 $17,000
Q3 2020 Oct 09, 2020	BUY	$47.45 - $62.95 $6,643 - $8,813	140 Added 16.67%	980 $47,000
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $2,692 - $3,263	50 Added 6.33%	840 $51,000
Q2 2019 Aug 01, 2019	SELL	$62.09 - $86.14 $620 - $861	-10 Reduced 1.25%	790 $51,000
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $2,168 - $2,977	-50 Reduced 5.88%	800 $48,000
Q4 2017 Jan 30, 2018	SELL	$50.3 - $64.39 $7,042 - $9,014	-140 Reduced 14.14%	850 $43,000
Q2 2017 Aug 22, 2017	BUY	N/A	990	990 $0

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.